(Q24246607)

1

0 references

Sally Hollis

3

0 references

Fenella Wojnarowska

4

0 references

Dedee F Murrell

Cochrane Database of Systematic Reviews

5

0 references

publication date

20 July 2005

0 references

published in

0 references

cites work

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

Chronic bullous dermatoses in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

21 January 2018

Pemphigoid in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

High risk of death in elderly patients with extensive bullous pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

The events leading to the death of patients with pemphigus and pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

Death in bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

Lack of predictive factors for the clinical course of bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

A systematic review of treatments for bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

7 January 2021

Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

7 January 2021

Bioavailability and reversible metabolism of prednisone and prednisolone in man

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

7 January 2021

Plasma exchange in bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

7 January 2021

Localization of bullous pemphigoid antibody--an indirect immunofluorescence study of 228 cases using a split-skin technique

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

7 January 2021

Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

7 January 2021

Bullous diseases in Malaysia: epidemiology and natural history

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

7 January 2021

Bullous pemphigoid: clinico-epidemiological study of patients seen at a Singapore skin hospital

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

7 January 2021

Azathioprine plus prednisone in treatment of pemphigoid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

7 January 2021

Clinical, histological and immunological studies in 50 patients with bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002292.PUB2

7 January 2021